Treating indolent and mantle cell lymphoma: results of the BRIGHT 5 year follow up study
Current standard of care for patients who are eligible for autologous stem cell transplantation
AML clinical trials: early stage vs. relapse/refractory patients
Lessons from the ASPIRE trial: three drug regimens as the new SOC for relapsed MM
Why has the biobank project been a success and what is the future for it?
Regis Peffault de Latour